» Articles » PMID: 28970158

Predictors of Poor Treatment Outcomes in Multidrug-resistant Tuberculosis Patients: a Retrospective Cohort Study

Overview
Publisher Elsevier
Date 2017 Oct 4
PMID 28970158
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: We aimed to determine the characteristics, treatment outcomes and risk factors for poor treatment outcomes among multidrug-resistant (MDR) tuberculosis (TB) patients in Khyber Pakhtunkhwa province, Pakistan.

Methods: A retrospective cohort study including all patients with MDR-TB who sought care at the MDR-TB unit in Peshawar was conducted between January 2012 and April 2014. Patients were followed until an outcome of TB treatment was recorded as successful (cured or completed) or unsuccessful. Binary logistic regression was used to identify predictors of poor outcome, i.e. unsuccessful treatment outcomes.

Results: Overall, 535 patients were included. The proportion of female subjects was relatively higher (n = 300, 56.1%) than male subjects. The mean (standard deviation) age of patients was 30.37 (14.09) years. Of 535 patients for whom treatment outcomes were available, 402 (75.1%) were cured, 4 (0.7%) completed therapy, 34 (6.4%) had disease that failed to respond to therapy, 93 (17.4%) died and two (0.4%) defaulted; in total, 129 (24.1%) had an unsuccessful outcome. We found three significant predictors of unsuccessful treatment during multivariate logistic regression: being married (odds ratio (OR) = 2.17, 95% confidence interval (CI) 1.01, 4.66), resistance to second-line drugs (OR = 2.61, 95% CI 1.61, 4.21) and presence of extensively drug-resistant TB (OR = 7.82, 95% CI 2.90, 21.07).

Conclusions: Approximately 75% of the treatment success rate set by the Global Plan to Stop TB was achieved. Resistance to second-line drugs and presence of extensively drug-resistant TB are the main risk factors for poor treatment outcomes.

Citing Articles

Using Unannounced Standardized Patients to Assess the Quality of Tuberculosis Care and Antibiotic Prescribing: A Cross-Sectional Study on a Low/Middle-Income Country, Pakistan.

Zhao M, Gillani A, Hussain H, Arshad H, Arshed M, Fang Y Antibiotics (Basel). 2025; 14(2).

PMID: 40001418 PMC: 11852056. DOI: 10.3390/antibiotics14020175.


Determinants of unfavourable treatment outcomes of drug-resistant tuberculosis cases in Malaysia: a case-control study.

Kamarul Zaman M, Nik Husain N, Sidek M, Abu Bakar Z BMJ Open. 2025; 15(2):e093391.

PMID: 39965941 PMC: 11836788. DOI: 10.1136/bmjopen-2024-093391.


Experience of piloting BPaLM/BPaL for DR-TB care at selected sites in Pakistan.

Ismail A, Ghafoor A, Khan N, Muzaffar N, Zafar F, Gupta A IJTLD Open. 2024; 1(11):508-515.

PMID: 39544887 PMC: 11558782. DOI: 10.5588/ijtldopen.24.0369.


A pharmacometric multistate model for predicting long-term treatment outcomes of patients with pulmonary TB.

Lin Y, Zou Y, Karlsson M, Svensson E J Antimicrob Chemother. 2024; 79(10):2561-2569.

PMID: 39087258 PMC: 11441995. DOI: 10.1093/jac/dkae256.


mHealth application for improving treatment outcomes for patients with multidrug-resistant tuberculosis in Vietnam: an economic evaluation protocol for the V-SMART trial.

Cheng Q, Dang T, Nguyen T, Velen K, Nguyen V, Nguyen B BMJ Open. 2023; 13(12):e076778.

PMID: 38081668 PMC: 10729151. DOI: 10.1136/bmjopen-2023-076778.